Livanova Stock News

Stock analysts at The Goldman Sachs Group started coverage on shares of LivaNova (NASDAQ:LIVN) in a report issued on Friday, The Fly reports. The firm set a buy rating and a $108.00 price target on the stock. The Goldman Sachs Groups target price would indicate a potential upside of 31.26% from the stocks previous close. []

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its participation in the American Epilepsy Society (AES) Annual Meeting taking place Decembe

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its participation in the 4th International Brain Stimulation Conference, taking place Decemb

Cardiopulmonary Autotransfusion System is a sophisticated device with a remarkably effective design that provides autologous blood during surgical procedures. Autologous red blood cell salvage is a safe, reliable, and cost-effective technique of returning washed red blood cells to a patient.

Invesco Ltd. grew its holdings in shares of LivaNova PLC (NASDAQ:LIVN) by 11.0% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 85,512 shares of the companys stock after acquiring an additional 8,461 shares during the quarter. Invesco Ltd. owned 0.17% []

Viveve Medical (NASDAQ:VIVE) and LivaNova (NASDAQ:LIVN) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, analyst recommendations, institutional ownership, risk, earnings, valuation and dividends. Valuation & Earnings This table compares Viveve Medical and LivaNovas revenue, earnings per share (EPS) and valuation. []

Wedge Capital Management L L P NC lowered its holdings in shares of LivaNova PLC (NASDAQ:LIVN) by 4.8% in the 3rd quarter, Holdings Channel.com reports. The fund owned 120,918 shares of the companys stock after selling 6,054 shares during the period. Wedge Capital Management L L P NCs holdings in LivaNova were worth $9,575,000 at []

The Global Adult and Pediatric Hemoconcentrators Market, by Product Type (Adult Hemoconcentrators and Pediatric Hemoconcentrators), by End User (Hospital, Ambulatory Surgical Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), was valued

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced that Damien McDonald, Chief Executive Officer, will participate in discussions at the Piper …

LONDON--(BUSINESS WIRE)-- #cardiovascular--LivaNova PLC announced Damien McDonald, CEO, will participate in discussions at the Piper Sandler 33rd Annual Virtual Healthcare Conference on Dec. 1.

Global Transcatheter Aortic Valve Replacement (TAVR) Market Synopsis: DBMR team offers customization of Transcatheter Aortic Valve Replacement (TAVR) Market report according to the business needs. Contact sales team, who will guarantee to get a report that suits the necessities. The Market

Related Stocks: LIVN , SEER , GKOS , NSTG , CUTR , LUNG , MAPS , COO , CANO , OLPX , SLGC , CNVY , INOV , ORGO , LLY , CMIIU , PROF , XENT ,

The courts in Milan ruled that LivaNova would be liable for $519 million in damages in connection with a former parent company from Sorin with which it merged years ago.

Royal Bank of Canada lessened its holdings in LivaNova PLC (NASDAQ:LIVN) by 8.1% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 95,010 shares of the companys stock after selling 8,336 shares during the quarter. Royal Bank of Canadas holdings in LivaNova were worth $7,991,000 as of its most recent SEC filing. Other hedge []

LONDON--(BUSINESS WIRE)-- #cardiovascular--LivaNova announced CEO Damien McDonald will present at Stifel 2021 Virtual Healthcare Conference and at Jefferies 2021 London Healthcare Conference.